Med Business World

Your source for healthcare business

Bavarian Nordic

Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland

Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved JYNNEOS® (MVA-BN) for active immunization against disease caused by smallpox, mpox and vaccinia viruses in adults 18 years of age and older. The approval…